At the core of this framework is the critical role glycolysis plays in rapid ATP generation necessary for essential cellular processes. Glycolysis serves as the primary source of quick energy fueling cell proliferation, DNA synthesis, and mitochondrial maintenance. Taguchi and colleagues argue that an age-dependent decrease in glycolytic ATP supply progressively weakens these vital repair and regeneration mechanisms, fundamentally shaping the phenotypes of aging observed throughout the animal kingdom.

This theory diverges significantly from classical aging hypotheses that focus predominantly on oxidative damage accumulation or telomere shortening. Instead, it posits that the metabolic shift away from glycolysis towards oxidative phosphorylation, while more energy-efficient, compromises the quick ATP availability required for immediate cellular repair. The consequent decline in repair capability leads to the accumulation of molecular and organellar damage that typifies aging tissues.

The researchers substantiate their argument with comparative biology evidence, contrasting short-lived rodents with long-lived species like the naked mole rat. Notably, naked mole rats sustain high glycolytic flux even in low-oxygen microenvironments, enabling continuous ATP production and exceptional longevity. Such observations suggest that species have evolved distinct metabolic strategies to balance energy efficiency and repair capacity optimally over their lifespans.

Furthermore, the perspective elucidates molecular pathways linking glycolytic ATP production to cellular quality control processes such as mitophagy, telomere dynamics, and proteostasis. Sustaining high glycolytic flux supports these pathways, ensuring maintenance of genomic integrity and proteome stability, thereby delaying age-associated functional decline. Conversely, an enforced metabolic transition to oxidative phosphorylation reduces glycolytic contributions, undermining these protective networks and hastening aging.

The authors also consider the evolutionary rationale, proposing that natural selection favored species with an optimal rate of glycolytic ATP decline. Species exhibiting either too rapid or too slow a reduction in glycolytic capacity would likely suffer fitness disadvantages, underscoring aging as an evolved, regulated process rather than mere wear-and-tear. This contention reframes aging as a metabolically programmed trajectory sculpted by energy allocation priorities across generations.

To rigorously test this provocative hypothesis, Taguchi’s team delineates several experimental avenues. These include genetic and pharmacologic interventions to modulate glycolytic enzyme activity in vivo and in vitro. For instance, gene transfer approaches targeting key glycolytic enzymes or application of drugs like terazosin, known to stimulate glycolysis, could ascertain if enhancing glycolytic ATP production rejuvenates repair systems and extends cellular and organismal longevity.

Additionally, longitudinal studies measuring glycolytic ATP output across age cohorts in diverse species with varying lifespans will be critical to delineate the “optimal rate” of glycolytic decline. Complementary comparative analyses could identify metabolic signatures linked to longevity, enabling predictive models of aging based on metabolic profiling. These efforts aim to connect molecular metabolism with evolutionary biology and lifespan determination.

A particularly novel aspect under investigation is metabolic coupling via gap junctions between hematopoietic stem cells and endothelial cells, a potential mechanism for distributing glycolytic ATP to critical regenerative niches. Deciphering such intercellular energy-sharing networks could uncover new targets for therapeutic intervention to mitigate age-related degeneration across tissue systems.

Despite the compelling coherence of the model, the authors emphasize its current status as a hypothesis requiring empirical validation. They caution that translation into human therapies—whether stem cell-based, metabolic activators, or gene therapies—demands meticulous preclinical evaluation of safety, efficacy, and long-term outcomes. Moreover, the evolutionary basis warrants deeper mechanistic and comparative research to substantiate the concept of a selected, programmed glycolytic decline.

This paradigm-shifting perspective invites a fundamental reconsideration of aging biology, highlighting the pivotal influence of glycolytic metabolism in lifespan regulation. It postulates that rather than oxidative damage alone, an orchestrated modulation of glycolytic ATP generation orchestrates the balance between energy efficiency, rapid repair capacity, and longevity. If borne out, such insights could revolutionize strategies aimed at extending healthspan and counteracting age-related diseases.

By uniting metabolic biochemistry, evolutionary theory, and aging physiology, this work sets the stage for a new era in aging research. It challenges researchers to explore glycolytic flux not just as a metabolic parameter, but as a central determinant of biological aging trajectories shaped by natural selection. Unlocking the molecular levers of glycolytic control could soon provide revolutionary avenues to delay aging and promote regenerative health in humans.

As this hypothesis undergoes further experimental scrutiny, it promises to inspire transformative innovations in anti-aging science, catalyzing developments from bench to bedside. Future studies dissecting glycolytic regulation within specific stem cell populations and tissue microenvironments will be critical to delineate mechanistic underpinnings and therapeutic potential. The tantalizing prospect of metabolically reprogramming aging processes may herald a new frontier in gerontology and regenerative medicine.

The research spearheaded by Taguchi and collaborators opens fresh intellectual vistas linking metabolic flux with lifespan modulation, presenting a refined, integrative narrative of aging biology. As the field embraces this interplay between energy metabolism and aging phenotypes, novel biomarkers and interventions targeting glycolytic pathways are poised to emerge. Ultimately, this framework could redefine our approach to prolonging longevity and enhancing resilience against age-associated decline.

Subject of Research:
Not applicable

Article Title:
A decline in glycolytic ATP production is the fundamental mechanism limiting lifespan; species with an optimal rate of decline over time survived

News Publication Date:
24-Feb-2026

Web References:
https://doi.org/10.18632/aging.206356
https://www.aging-us.com/issue/v18i1/

Image Credits:
Copyright: © 2026 Taguchi et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0).

Keywords:
hypothesis, aging, glycolytic ATP production, lifespan, Heterocephalus glaber

Cell proliferation demands a harmonized interplay between energy generation and macromolecular synthesis processes, yet the precise molecular controls that synchronize these complex cellular events have remained elusive. The latest research delves deeply into the transient inactivation of the APC/C, an essential ubiquitin ligase complex known for its role in protein degradation during mitosis, demonstrating its unexpected regulatory function at the cusp of cell cycle re-initiation from quiescence. This discovery provides compelling evidence that APC/C inactivation is not merely a consequence of cell cycle progression, but a proactive switch to reshape the cell’s metabolic framework.

Through innovative experimental approaches utilizing MCF-10A human mammary epithelial cells, the research team specifically manipulated the phosphorylation status of CDH1 at threonine 129, creating mutants that either mimic persistent phosphorylation (T129D) or prevent phosphorylation (T129A). The expression of the CDH1(T129A) mutant, which enforces continuous APC/C activation, was found to profoundly inhibit CDK2 activation, a key driver of cell cycle progression, effectively reducing the number of cells entering the cell cycle. Conversely, the CDH1(T129D) mutant, unable to efficiently bind and activate APC/C, showed minimal impact on cell cycle entry, underscoring the necessity of transient APC/C inactivation for proper proliferation.

Central to the study’s findings is the transient accumulation of PFKFB3, a critical glycolytic activator, whose protein stability hinges on APC/C activity. The researchers revealed that transient APC/C inactivation allows for a sharp and timely burst in PFKFB3 levels, elevating glycolytic flux to meet the heightened biosynthetic and energetic demands during early cell cycle re-entry. Pharmacological inhibition of PFKFB3 using PFK15 mirrored the effects of persistent APC/C activation, further validating the dependency of cell cycle entry on glycolytic reprogramming facilitated by APC/C modulation.

Notably, the team employed sophisticated single-cell CDK2 activity biosensors coupled with time-resolved manipulations of CDH1 phosphorylation status and glycolytic enzyme activity to delineate the temporal windows in which these molecular events are critical. They found that even transient perturbations limited to the initial 6-8 hours following mitogen stimulation were sufficient to significantly impair cell cycle progression, highlighting the exquisitely timed nature of APC/C inactivation and glycolytic enhancement during the early G1 phase.

This finely tuned regulatory circuit appears to be driven upstream by mTOR signaling, a master metabolic regulator often implicated in growth control and nutrient sensing. mTOR-mediated phosphorylation of CDH1 transiently suppresses APC/C activity, temporarily lifting suppression on PFKFB3 and possibly other metabolic enzymes. Subsequently, protein phosphatases act to reactivate APC/C by dephosphorylating CDH1, restoring its function and thus creating a dynamic “on-off” switch that balances protein degradation with metabolic demands.

The implications of this discovery extend far beyond basic cell biology, offering novel insights into how disruptions in metabolic regulation can impact diseases characterized by uncontrolled proliferation, including cancer. Given that the Warburg effect — a phenomenon where cancer cells exhibit elevated glycolysis even in oxygen-rich conditions — mirrors the metabolic switch observed here, understanding APC/C’s role may open new avenues for targeted therapies that exploit this transient vulnerability during cell cycle re-entry.

Moreover, this research prompts a reevaluation of APC/C’s traditional perception solely as a mitotic regulator, positioning it as a critical integrator of metabolism and cell cycle machinery. This dual functionality ensures that energy production and biosynthesis are precisely aligned with proliferative signals, thereby safeguarding cellular homeostasis during the demanding process of cell cycle transition from quiescence.

The methodology employed in this study leverages precise genetic and pharmacological tools combined with live-cell imaging, enabling a dissection of temporal dynamics that were previously inaccessible through bulk population analyses. Such single-cell resolution elucidates heterogeneity in cell cycle entry decisions, shedding light on how individual cells interpret and respond to mitogenic cues within their metabolic context.

Furthermore, this work emphasizes the importance of post-translational modifications in regulating complex cellular networks. The phosphorylation-dephosphorylation cycles of CDH1 act as molecular toggles, governing APC/C activity and thus dynamically modulating substrate stability in response to fluctuating intra- and extracellular signals. Such mechanisms underscore the plasticity and adaptability of cell regulatory systems.

By connecting mTOR signaling with APC/C and glycolytic control, the study also integrates two previously disparate fields — nutrient sensing/metabolic regulation and cell cycle control — into a coherent framework that explains how proliferative cues translate into metabolic remodeling necessary for successful cell division.

In conclusion, the discovery that transient APC/C inactivation induced by mTOR-dependent phosphorylation of CDH1 orchestrates a metabolic switch to glycolysis provides a conceptual advance in cell biology. This coordination ensures that energy and biosynthetic needs are met precisely at the moment cells commit to division. These findings not only deepen our understanding of cellular proliferation but also lay the groundwork for innovative therapeutic strategies targeting metabolic vulnerabilities linked to cell cycle dysregulation.

Subject of Research: The coordination of cell cycle entry and metabolic reprogramming via transient APC/C inactivation mediated by mTOR-dependent phosphorylation of CDH1, focusing on glycolytic regulation and its impact on proliferation.

Article Title: Transient APC/C inactivation by mTOR boosts glycolysis during cell cycle entry.

Article References:
Paul, D., Bolhuis, D.L., Yan, H. et al. Transient APC/C inactivation by mTOR boosts glycolysis during cell cycle entry. Nature (2025). https://doi.org/10.1038/s41586-025-09328-w

Image Credits: AI Generated